α3β1 has been implicated as a potential marker protein for cells undergoing enhanced EMT or for cancer cells with aggressive phenotypes [37], and the transcription factor Ets-1 may play role in transcriptional activation of the α3 subunit gene [47]. The gene discussed is ETS1; the disease is cancer.